Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

Lilly CEO rejects a decade-long AI disease-cure timeline

AI summary

Eli Lilly CEO Dave Ricks said it is unlikely AI will cure cancer and other major diseases within a decade, according to IT之家. He cited gaps in biological understanding and the bottleneck of randomized human trials, while expressing optimism that AI will produce steady, gradual progress in drug development. Gary Marcus amplified the disagreement by calling Anthropic CEO Dario Amodei’s timeline unrealistic.

In-depth insight

Ricks’s argument highlights the clinical-validation constraints behind AI-driven medical predictions, providing a counterpoint to Amodei’s optimistic roadmap.

This source provides an excerpt. Continue reading on the original site.

#Anthropic#Eli Lilly

Read the original
Group chat

No comments yet. Start the conversation.